AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $8,940,000 | -6.6% | 400,000 | 0.0% | 0.02% | -18.5% |
| Q4 2018 | $9,568,000 | -45.3% | 400,000 | -27.3% | 0.03% | -34.1% |
| Q1 2018 | $17,507,000 | -64.4% | 550,000 | -57.7% | 0.04% | -63.1% |
| Q4 2017 | $49,166,000 | +22.9% | 1,300,000 | -19.4% | 0.11% | +14.4% |
| Q3 2017 | $39,997,000 | +2.4% | 1,613,452 | -15.1% | 0.10% | +1.0% |
| Q2 2017 | $39,064,000 | +44.8% | 1,900,000 | +53.1% | 0.10% | +41.2% |
| Q1 2017 | $26,976,000 | +15.6% | 1,241,400 | +8.8% | 0.07% | +6.2% |
| Q4 2016 | $23,342,000 | +39.4% | 1,141,400 | +2.2% | 0.06% | +39.1% |
| Q3 2016 | $16,746,000 | +38.6% | 1,116,400 | 0.0% | 0.05% | +39.4% |
| Q2 2016 | $12,079,000 | -22.0% | 1,116,400 | -2.2% | 0.03% | -21.4% |
| Q1 2016 | $15,477,000 | -26.5% | 1,141,400 | 0.0% | 0.04% | -23.6% |
| Q4 2015 | $21,059,000 | -33.0% | 1,141,400 | -8.1% | 0.06% | -36.8% |
| Q3 2015 | $31,423,000 | – | 1,241,400 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|